Éva Bakos - Search Results

Year	Number of Results
2002	2
2003	3
2004	2
2006	1
2007	2
2008	1
2009	1
2017	1
2018	2
2019	1
2020	7
2021	5
2022	0

1

Creation of the first monoclonal antibody recognizing an extracellular epitope of hABCC6.

Kozák E, Szikora B, Iliás A, Jani PK, Hegyi Z, Matula Z, Dedinszki D, Tőkési N, Fülöp K, Pomozi V, Várady G, Bakos É, Tusnády GE, Kacskovics I, Váradi A. Kozák E, et al. Among authors: bakos e. FEBS Lett. 2021 Mar;595(6):789-798. doi: 10.1002/1873-3468.13991. Epub 2020 Nov 28. FEBS Lett. 2021. PMID: 33159684 Free article.

2

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters.

Telbisz Á, Ambrus C, Mózner O, Szabó E, Várady G, Bakos É, Sarkadi B, Özvegy-Laczka C. Telbisz Á, et al. Among authors: bakos e. Pharmaceutics. 2021 Jan 9;13(1):81. doi: 10.3390/pharmaceutics13010081. Pharmaceutics. 2021. PMID: 33435273 Free PMC article.

3

Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions.

Székely V, Patik I, Ungvári O, Telbisz Á, Szakács G, Bakos É, Özvegy-Laczka C. Székely V, et al. Among authors: bakos e. Eur J Pharm Sci. 2020 Aug 1;151:105395. doi: 10.1016/j.ejps.2020.105395. Epub 2020 May 29. Eur J Pharm Sci. 2020. PMID: 32473861 Free article.

4

Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics.

Ambrus C, Bakos É, Sarkadi B, Özvegy-Laczka C, Telbisz Á. Ambrus C, et al. Among authors: bakos e. Sci Rep. 2021 Sep 8;11(1):17810. doi: 10.1038/s41598-021-97160-3. Sci Rep. 2021. PMID: 34497279 Free PMC article.

5

Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting polypeptide 2B1 (OATP2B1).

Laczkó-Rigó R, Bakos É, Jójárt R, Tömböly C, Mernyák E, Özvegy-Laczka C. Laczkó-Rigó R, et al. Among authors: bakos e. Toxicol Appl Pharmacol. 2021 Oct 15;429:115704. doi: 10.1016/j.taap.2021.115704. Epub 2021 Aug 30. Toxicol Appl Pharmacol. 2021. PMID: 34474082 Free article.

6

8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of Organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1.

Ungvári O, Király L, Bakos É, Özvegy-Laczka C. Ungvári O, et al. Among authors: bakos e. FASEB J. 2021 Sep;35(9):e21863. doi: 10.1096/fj.202100648R. FASEB J. 2021. PMID: 34411334

7

Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Bakos E, Homolya L. Bakos E, et al. Pflugers Arch. 2007 Feb;453(5):621-41. doi: 10.1007/s00424-006-0160-8. Epub 2006 Dec 23. Pflugers Arch. 2007. PMID: 17187268 Review.

8

P glycoprotein and the mechanism of multidrug resistance.

Váradi A, Szakács G, Bakos E, Sarkadi B. Váradi A, et al. Among authors: bakos e. Novartis Found Symp. 2002;243:54-65; discussion 65-8, 180-5. Novartis Found Symp. 2002. PMID: 11990782 Review.

9

Structural dissection of 13-epiestrones based on the interaction with human Organic anion-transporting polypeptide, OATP2B1.

Laczkó-Rigó R, Jójárt R, Mernyák E, Bakos É, Tuerkova A, Zdrazil B, Özvegy-Laczka C. Laczkó-Rigó R, et al. Among authors: bakos e. J Steroid Biochem Mol Biol. 2020 Jun;200:105652. doi: 10.1016/j.jsbmb.2020.105652. Epub 2020 Mar 6. J Steroid Biochem Mol Biol. 2020. PMID: 32147459 Free article.

10

The role of multidrug transporters in drug availability, metabolism and toxicity.

Bodó A, Bakos E, Szeri F, Váradi A, Sarkadi B. Bodó A, et al. Among authors: bakos e. Toxicol Lett. 2003 Apr 11;140-141:133-43. doi: 10.1016/s0378-4274(02)00497-6. Toxicol Lett. 2003. PMID: 12676459 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results